TISSIUM
tissium.com
Actively hiring
Manufacturing
Plastics & Polymers
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$68M
1 round on record
Latest round
$68M
Venture round · Jun 2026 · 3 mo ago
Team
50–99
French register · Dec 2023
Revenue
$10M
2025 · French register
Backers
2
Karista, Omnes Capital
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 5
New executive TISSIUM APPOINTS MARC QUARTULLI AS VICE PRESIDENT OF CLINICAL AFFAIRS · The Manila Times
2013
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2026 | $68M | — | mobihealthnews.com |
Founders and leadersfrom filings, registers and the company's site
Frank WatkinsPrésident du conseil d’administrationcompany register
Backed byfrom the funds' portfolios and accelerator catalogs
Karista 
Omnes Capital Similar startupsby what they do, their industry and backers
Finally. Affordable building blocks for the bioeconomy. Water-based chemistry for deconstructing plants into sugars and polymers.
Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free…
Partner with Distil for R&D-led speciality chemicals, flexible manufacturing, and end-to-end supply chain solutions across personal care…
GlycoLogix - A ground-breaking therapy for Interstitial Cystitis / Bladder Pain Syndrome, developing biopolymers for soft tissue repair.
Meet the scientists behind our solutions. It's Time for a Better Way Our Founding Scientific Team Mango Materials is comprised of…
Syntetica produces virgin-quality recycled nylon using green chemistry. Transforming textile waste into sustainable Nylon 6 & 6,6 for…
Overview
TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.
News
TISSIUM Secures €60 Million To Support Commercial And Clinical Expansion
TISSIUM announced a €60 million financing package to support its commercial and clinical activities, pipeline development, and platform expansion. The financing package includes a completed €30 million Series D2 financing and a financing facility of up to
Read more
Report
TISSIUM Selected to the French Tech Next40 Program
Paris, France, June 15, 2026 - TISSIUM, a medical technology company pioneering biomorphic programmable polymers for tissue reconstruction, today announced its selection to the French Tech Next40 Class of 2026. Following six consecutive years as a member
Read more
Report
TISSIUM APPOINTS MARC QUARTULLI AS VICE PRESIDENT OF CLINICAL AFFAIRS
Paris, France, Cambridge, USA, May 5th, 2026 - TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Marc Quartulli as its Vice President of Clinical Affairs.
Read more
Report
TISSIUM ANNOUNCES PUBLICATION OF FIRST-IN-HUMAN CLINICAL RESULTS OF THE COAPTIUM CONNECT SYSTEM FOR ATRAUMATIC SUTURELESS NERVE REPAIR IN JHSGO
Paris, France, Cambridge, USA, March 18, 2026 - TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, is pleased to announce the publication of its first-in-human clinical study in the Journal of Hand
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Frank Watkins
Président du conseil d’administration
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ
18 Avenue Léon Gaumont,
18 Avenue Léon Gaumont,, 75020 Paris France
Financials
Est. Annual Revenue
$10M
2025
Total raised
$68M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $68M | Details |